References
- LempMABaudoinCBaumJThe definition and classification of dry eye disease: report of the definition and classification subcommittee of the international dry eye workshop (2007)Ocul Surf200752759217508116
- SchaumbergDANicholsJJPapasEBTongLUchinoMNicholsKKThe international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGDInvest Ophthalmolol Vis Sci201152419942005
- PerryHDDonnenfeldEDDry eye diagnosis and management in 2004Curr Opin Ophthalmol200415429930415232468
- GürdalCSaraçOGençIKırımlıoğluHTakmazTCanIOcular surface and dry eye in Graves’ diseaseCurr Eye Res201136181321174592
- BothunEDScheurerRAHarrisonARLeeMSUpdate on thyroid eye disease and managementClin Ophthalmol2009354355119898626
- BurchHBWartofskyLGraves’ ophthalmopathy: current concepts regarding pathogenesis and managementEndocr Rev19931467477938119236
- MaheshwariRWeisEThyroid associated orbitopathyIndian J Ophthalmol2012602879322446901
- VillaniEViolaFSalaRCorneal involvement in Graves’ orbitopathy: an in vivo confocal studyInvest Ophthalmol Vis Sci20105194574457820435595
- BartleyGBFatourechiVKadrmasEFClinical features of Graves’ ophthalmopathy in an incidence cohortAm J Ophthalmol199612132842908597271
- BartleyGBFatourechiVKadrmasEFLong-term follow-up of Graves ophthalmopathy in an incidence cohortOphthalmol19961036958962
- MizenTRThyroid eye diseaseSemin Ophthalmol200318424324715513011
- BahnRSDuttonCMNattNJobaWSpitzwegCHeufelderAEThyrotropin receptor expression in Graves’ orbital adipose/connective tissues: potential autoantigen in Graves’ ophthalmopathyJ Clin Endo-crinol Metab19988339981002
- BahnRSHeufelderAEPathogenesis of Graves’ ophthalmopathyN Engl J Med199332920146814758413459
- SmithTJHoaNImmunoglobulins from patients with Graves’ disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptorJ Clin Endocrinol Metab200489105076508015472208
- YeattsRPQuality of life in patients with Graves ophthalmopathyTrans Am Ophthalmol Soc200510336841117057811
- MossSEKleinRKleinBEKPrevalence of and risk factors for dry eye syndromeArch Ophthalmol200011891264126810980773
- BuchholzPSteedsCSSternLSUtility assessment to measure the impact of dry eye diseaseOcul Surf20064315516116900272
- GalorAFeuerWLeeDJPrevalence and risk factors of dry eye syndrome in a United States veterans affairs populationAm J Ophthalmol20111523377e384e21684522
- KimKWHanSBHanERAssociation between depression and dry eye disease in an elderly populationInvest Ophthalmol Vis Sci201152117954795821896858
- LeeS-YPetznickATongLAssociations of systemic diseases, smoking and contact lens wear with severity of dry eyeOphthalmic Physiol Opt201232651852622958181
- TongLSawSMLamoureuxELA questionnaire-based assessment of symptoms associated with tear film dysfunction and lid margin disease in an Asian populationOphthalmic Epidemiol2009161313719191179
- NowakMMarekBKos-KudłaBKajdaniukDSiemińskaLTear film profile in patients with active thyroid orbithopathyKlin Oczna20051077–947948216417002
- AchtsidisVTentolourisNTheodoropoulouSDry eye in Graves ophthalmopathy: correlation with corneal hypoesthesiaEur J Ophthalmol201323447347923483512
- IsmailovaDSFedorovAGrushaYOOcular surface changes in thyroid eye diseaseOrbit2013322879023565763
- WernerSCClassification of the eye changes of Graves’ diseaseAm J Ophthalmol19696846466485394450
- MouritsMPPrummelMFWiersingaWMKoornneefLClinical activity score as a guide in the management of patients with Graves’ ophthalmopathyClin Endocrinol1997471914
- DolmanPJEvaluating Graves’ orbitopathyBest Pract Res Clin Endocrinol Metab201226322924822632361
- IskeleliGKarakocYAbdulaATear film osmolarity in patients with thyroid ophthalmopathyJpn J Ophthalmol200852432332618773272
- EcksteinAKFinkenrathAHeiligenhausARenzing-koKDry eye syndrome in thyroid-associated ophthalmopathy: lacrimal expression of TSH receptor suggests involvement of TSHR-specific autoantibodiesActa Ophthalmol Scand20048229129715115450
- KhuranaAKSunderSAhluwaliaBKMalhotraKCTear film profile in Graves’ ophthalmopathyActa Ophthalmol19927033463491636395
- GilbardJPFarrisRLOcular surface drying and tear film osmolarity in thyroid eye diseaseActa Ophthalmol19836111081166687972
- BrasilMVBrasilOFMVieiraRPVaismanMAmaral FilhoOMBTear film analysis and its relation with palpebral fissure height and exophthalmos in Graves’ ophthalmopathyArq Bras Oftalmol200568561561816322856
- LuoLLiD-QDoshiAFarleyWCorralesRMPflugfelderSCExperimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surfaceInvest Ophthalmol Vis Sci200445124293430115557435
- LuoLLiD-QCorralesRMPflugfelderSCHyperosmolar saline is a proinflammatory stress on the mouse ocular surfaceEye Contact Lens200531518619316163009
- El AnnanJChauhanSKEcoiffierTZhangQSabanDRDanaRCharacterization of effector T cells in dry eye diseaseInvest Ophthalmol Vis Sci20095083802380719339740
- GürdalCGençISaraçOGönülITakmazTCanITopical cyclosporine in thyroid orbitopathy-related dry eye: clinical findings, conjunctival epithelial apoptosis, and MMP-9 expressionCurr Eye Res201035977177720795858
- GilbardJPCarterJBSangDNRefojoMFHanninenLAKenyonKRMorphologic effect of hyperosmolarity on rabbit corneal epitheliumOphthalmology19849110120512126514286
- GumusKCavanaghDHThe role of inflammation and anti-inflammation therapies in keratoconjunctivitis siccaClin Ophthalmol20093576719668545
- RochaEMMantelliFNominatoLFBoniniSHormones and dry eye syndrome: an update on what we do and don’t knowCurr Opin Ophthalmol201324434835523680756
- HarrisMARealiniTHoggJPSivak-CallcottJACT dimensions of the lacrimal gland in Graves orbitopathyOphthal Plast Reconstr Surg20122816972
- MoncayoRBaldisseraIDecristoforoCKendlerDDonnemillerEEvaluation of immunological mechanisms mediating thyroid-associated ophthalmopathy by radionuclide imaging using the somatostatin analog 111In-octreotideThyroid19977121299086565
- KhalilHADe KeizerRJBodelierVMKijlstraASecretory IgA and lysozyme in tears of patients with Graves’ ophthalmopathyDoc Ophthalmol1989723–43293342625093
- KhalilHAde KeizerRJKijlstraAAnalysis of tear proteins in Graves’ ophthalmopathy by high performance liquid chromatographyAm J Ophthalmol198810621861903400761
- KoulouliasVKouvarisJZygogianniAEfficacy and toxicity of radiotherapy for Graves’ ophthalmopathy: the University of Athens experienceHead Neck Oncol20135212
- PrabhuRSLiebmanLWojnoTHayekBHallWACrockerIClinical outcomes of radiotherapy as initial local therapy for Graves’ ophthalmopathy and predictors of the need for post-radiotherapy decompressive surgeryRadiat Oncol201279522713684
- MatthiesenCThompsonJSThompsonDThe efficacy of radiation therapy in the treatment of Graves’ orbitopathyInt J Radiat Oncol Biol Phys201282111712321030157
- GeorgeJNancy-braboisCHUNancyVOftalmologiaCMedicinaFRisk of dry eye after mullerectomy via the posterior conjunctival approach for thyroid-related upper eyelid retractionOrbit200233192612029578
- SokolJFoulksGNHaiderANuneryWROcular surface effects of thyroid diseaseOcul Surf201081293920105405
- HollyFJLambertsDWEffect of nonisotonic solutions on tear film osmolalityInvest Ophthalmol Vis Sci19812022362457461925
- CorralesRMLuoLChangEYPflugfelderSCEffects of osmopro-tectants on hyperosmolar stress in cultured human corneal epithelial cellsCornea200827557457918520508
- PflugfelderSCAnti-inflammatory therapy of dry eyeOcul Surf200311313617075627
- FoulksGNTopical cyclosporine for treatment of ocular surface diseaseInt Ophthalmol Clin200646410512217060797
- AltiparmakUEAcarDEOzerPATopical cyclosporine A for the dry eye findings of thyroid orbitopathy patientsEye20102461044105019834507
- PerryHDSolomonRDonnenfeldEDEvaluation of topical cyclosporine for the treatment of dry eye diseaseArch Ophthalmol200812681046105018695097